NHS National Generic Pharmaceuticals Wave 13

A Contract Award Notice
by ATAMIS LTD

Source
Contracts Finder
Type
Framework (Products)
Duration
28 month
Value
£470M
Sector
HEALTH
Published
22 Jul 2022
Delivery
01 Feb 2022 to 31 May 2024
Deadline
26 Jul 2021 13:00

Concepts

Location

Geochart for 1 buyers and 99 suppliers

1 buyer

99 suppliers

Description

Invitation to offer for NHS National Generic Pharmaceuticals Wave 13 Offer reference number: CM/PHG/17/5532 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 28 months, with an option or options to extend (at the Authority's sole discretion) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement: Transition (Everolimus) CESW: 1 March 2022 - 30 September 2023 (19 months) LSNE: 1 March 2022 - 31 January 2023 (11 months) NWLN: 1 March 2022 - 31 January 2023 (11 months) Oral Products plus non-parenterals All Regions: 1 March 2022 - 31 May 2024 (27 months) Hospital Only Products CESW: 1 February 2022 - 30 September 2023 (20 months) LSNE: 1 February 2022 - 31 May 2024 (28 months) NWLN: 1 February 2022 - 31 January 2023 (12 months)

Award Detail

1 Pfizer (None)
  • Value: £469,741,550
2 Merck Sharpe & Dohme (London)
  • Value: £469,741,550
3 Allergan (Marlow)
  • Value: £469,741,550
4 Medreich (Weybridge)
  • Value: £469,741,550
5 Ennogen Healthcare (Dartford)
  • Value: £469,741,550
6 Glaxosmithkline (London)
  • Value: £469,741,550
7 Syri (Ruislip)
  • Value: £469,741,550
8 Hameln Pharma (Gloucester)
  • Value: £469,741,550
9 Medac Pharma (Stirling)
  • Value: £469,741,550
10 Martindale Pharma (Romford)
  • Value: £469,741,550
11 Rosemont Pharmaceuticals (Leeds)
  • Value: £469,741,550
12 Mercury Pharmaceuticals (London)
  • Value: £469,741,550
13 Selective Supplies (London)
  • Value: £469,741,550
14 Nexcape Pharmaceuticals (London)
  • Value: £469,741,550
15 Consilient Health (Richmond upon Thames)
  • Value: £469,741,550
16 Sandoz (Camberley)
  • Value: £469,741,550
17 Fresenius Kabi (Runcorn)
  • Value: £469,741,550
18 Glenmark Pharmaceuticals Europe (Watford)
  • Value: £469,741,550
19 Laboratorio Reig Jofre (Bideford)
  • Value: £469,741,550
20 Kent Pharma (Heathrow)
  • Value: £469,741,550
21 Bowmed Ibisqus (Manchester)
  • Value: £469,741,550
22 Panpharma (Liverpool)
  • Value: £469,741,550
23 Kensington Pharma (Preston)
  • Value: £469,741,550
24 Healthcare Pharma (Haslemere)
  • Value: £469,741,550
25 Thornton & Ross (Huddersfield)
  • Value: £469,741,550
26 Mylan (Potters Bar)
  • Value: £469,741,550
27 Macleods Pharma (Billingham)
  • Value: £469,741,550
28 Wockhardt (Wrexham)
  • Value: £469,741,550
29 Thea Pharmaceuticals (Keele)
  • Value: £469,741,550
30 DR Falk Pharma (Bourne End)
  • Value: £469,741,550
31 Desitin Pharma (Woking)
  • Value: £469,741,550
32 Stragen (Horsham)
  • Value: £469,741,550
33 B Braun Medical (Sheffield)
  • Value: £469,741,550
34 Torrent Pharma (Crawley)
  • Value: £469,741,550
35 Fontus Health (Walsall)
  • Value: £469,741,550
36 Aspire Pharma (Godalming)
  • Value: £469,741,550
37 Teva (Castleford)
  • Value: £469,741,550
38 Amarox (Harrow)
  • Value: £469,741,550
39 Aop Orphan (Weybridge)
  • Value: £469,741,550
40 Pierre Fabre (London)
  • Value: £469,741,550
41 Macure Pharma Aps (Copenhagen)
  • Value: £469,741,550
42 Ranbaxy (Hayes)
  • Value: £469,741,550
43 Arcadia Pharma (Fforestfach)
  • Value: £469,741,550
44 Derma (Ouseburn)
  • Value: £469,741,550
45 Zista Pharma (Stevenage)
  • Value: £469,741,550
46 Drreddys Laboratories (Beverley)
  • Value: £469,741,550
47 Aspen Pharmacare (Maidenhead)
  • Value: £469,741,550
48 Manx Healthcare (Warwick)
  • Value: £469,741,550
49 Colonis Pharma (London)
  • Value: £469,741,550
50 Roche Products (Welwyn Garden City)
  • Value: £469,741,550
51 Waverley Pharma Europe (None)
  • Value: £469,741,550
52 Profile Pharma (Chichester)
  • Value: £469,741,550
53 Reckitt Benckiser (Slough)
  • Value: £469,741,550
54 Zentiva Pharma (London)
  • Value: £469,741,550
55 Baxter Healthcare (Thetford)
  • Value: £469,741,550
56 Organon Pharmaceuticals (London)
  • Value: £469,741,550
57 Day Lewis Medical (Croydon)
  • Value: £469,741,550
58 Logixx Pharma (Reading)
  • Value: £469,741,550
59 Lundbeck (Watford)
  • Value: £469,741,550
60 Napp Pharmaceuticals (Cambridge)
  • Value: £469,741,550
61 Bayer (Reading)
  • Value: £469,741,550
62 Recordati Rare Diseases (Maidenhead)
  • Value: £469,741,550
63 Morningside Pharmaeuticals (Northampton)
  • Value: £469,741,550
64 Dexcel Pharma (Daventry)
  • Value: £469,741,550
65 CST Pharma (Walsall)
  • Value: £469,741,550
66 Cipla Eu (Addlestone)
  • Value: £469,741,550
67 Flexipharm Austrading (Bourne End)
  • Value: £469,741,550
68 Relonchem (Widnes)
  • Value: £469,741,550
69 Leo Pharma (Hurley)
  • Value: £469,741,550
70 Aguettant (Bristol)
  • Value: £469,741,550
71 Torbay Pharmaceuticals (Paignton)
  • Value: £469,741,550
72 RPH Pharmaceuticals (Cheadle)
  • Value: £469,741,550
73 Drugsrus (Northwood)
  • Value: £469,741,550
74 Ferring Pharmaceuticals (West Drayton)
  • Value: £469,741,550
75 Milpharm (South Ruislip)
  • Value: £469,741,550
76 Pari (London)
  • Value: £469,741,550
77 Crescent Pharma (Basingstoke)
  • Value: £469,741,550
78 Roma Pharmaceuticals (Burton upon Trent)
  • Value: £469,741,550
79 Kyowa Kirin (Galashiels)
  • Value: £469,741,550
80 Brown & Burk (Hounslow)
  • Value: £469,741,550
81 Seacross Pharmaceuticals (London)
  • Value: £469,741,550
82 Lupin Healthcare (Slough)
  • Value: £469,741,550
83 Alliance Pharmaceuticals (Chippenham)
  • Value: £469,741,550
84 Bristol Laboratories (Berkhamsted)
  • Value: £469,741,550
85 Aristo Pharma (Ely)
  • Value: £469,741,550
86 Synchrony (Stevenage)
  • Value: £469,741,550
87 Alissa Healthcare Research (Fareham)
  • Value: £469,741,550
88 Altan Pharma (None)
  • Value: £469,741,550
89 Lucane Pharma (Ankeveen)
  • Value: £469,741,550
90 Norgine Pharmaceuticals (Uxbridge)
  • Value: £469,741,550
91 Neon Healthcare (Hertford)
  • Value: £469,741,550
92 Aventis Pharma (Reading)
  • Value: £469,741,550
93 Mip Pharma (Blieskastel Niederwuerzbach)
  • Value: £469,741,550
94 Accord (Barnstaple)
  • Value: £469,741,550
95 Acium (Stevenage)
  • Value: £469,741,550
96 Ascend Laboratories (London)
  • Value: £469,741,550
97 Rivopharm (London)
  • Value: £469,741,550
98 Strides Pharma (Watford)
  • Value: £469,741,550
99 V Pharma (None)
  • Value: £469,741,550

CPV Codes

  • 33600000 - Pharmaceutical products

Indicators

  • Contract is suitable for SMEs.

Reference

Domains